SEARCH

SEARCH BY CITATION

References

  • 1
    Roizen R, Kerr WC, Filmore KM. Cirrhosis mortality and per capita consumption of distilled spirits, United States 1949–1994 analysis. BMJ 1999; 319: 666.
  • 2
    Mc Master P. Transplantation for alcoholic liver disease in an era of organ shortage. Lancet 2000; 355: 424.
  • 3
    Neuberger J. Transplantation for alcoholic liver disease: a perspective from Europe. Liver Transplant Surg 1998; 4: S51.
  • 4
    Neuberger J, Adams D, Mc Master P, et al. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. Br Med J 1998; 317: 172.
  • 5
    Neuberger J, Schulz K-H, Day C, et al. Transplantation for alcoholic liver disease. J Hepatol 2002; 36: 130.
  • 6
    Hasin D, McCloud S, Li Q, Endicott J. Cross-system agreement among demographic subgroups: DSM-III, DSM-III-R, DSM-IV and ICD-10 diagnoses of alcohol use disorders. Drug Alcohol Depend 1996; 41: 127.
  • 7
    Walter M, Scholler G, Moyzes D, et al. Psychsocial prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Transplant Proc 2002; 34: 1239.
  • 8
    Tome S, Lucey MR. Current management of alcoholic liver disease. Aliment Pharmacol Ther 2004; 19: 1.
  • 9
    Carithers RL, Herlong HR, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. Ann Intern Med 1989; 110: 685.
  • 10
    Mutimer DJ, Burra P, Neuberger JM, et al. Managing severe alcoholic hepatitis complicated by renal failure. Quart J Med 1993; 86: 649.
  • 11
    Veldt BJ, Laine’ F, Guillygomarc'h A, et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: qualitative evaluation and optimal timing. J Hepatol 2002; 36: 93.
  • 12
    National Institutes of Health Consensus. National Institutes of Health Consensus Development Conference statement: liver transplantation. Hepatology 1984; 3: 107S.
  • 13
    Hoofnagle JH, Kresina T, Fuller RK, et al. Liver transplantation for alcoholic liver disease: executive statement and recommendations. Liver Transplant Surg 1997; 3: 347.
    Direct Link:
  • 14
    Poynard T, Naveau S, Doffoel M, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched simulated controls: 5-year survival. J Hepatol 1999; 30: 1130.
  • 15
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825.
  • 16
    Burra P, Mioni D, Cecchetto A, et al. Histological features after liver transplantation in alcoholic cirrhosis. J Hepatol 2001; 34: 716.
  • 17
    Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253.
  • 18
    Bruix J, Llovet JM. Prognostic prediction and treatment strategy in heptocellular carcinoma. Hepatology 2002; 35: 519.
  • 19
    Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
  • 20
    Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 12.
  • 21
    Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
  • 22
    Poynard T, Barthelmy P, Fratte S, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 1994; 344: 502.
  • 23
    Anand A, Ferraz-Neto B, Nightingale P, et al. J. Liver transplantation for alcoholic liver disease. Evaluation of a selection protocol. Hepatology 1997; 25: 14781484.
  • 24
    Sherman D, Williams R. Liver transplantation for alcoholic liver disease. J Hepatol 1995; 23: 474.
  • 25
    Shellito JE, Olariu R. Alcohol decrease T-lymphocyte migration into lung tissue in response to Pneumocystis carinii and depletes T-lymphocyte numbers in the spleen of mice. Alcohol Cklin Exp Res 1998; 22: 658.
  • 26
    Mason CM, Dobard E, Zhang P, Nelson S. Alcohol exacerbates murine pulmonary tubercolosis. Infect Immunol 2004; 72: 2556.
  • 27
    Kenngott S, Gerbes AL, Schauer R, Bilzer M. Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis. Transplant Int 2003; 16: 639.
  • 28
    Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the terapeuthic spectrum. Lancet Oncol 2004; 5: 409.
  • 29
    Veilhan LA, Adam R. Alcoholic liver cirrhosis. Treatment of hepatocellular carcinoma. Presse Med 2001; 30: 1170.
  • 30
    Gish RG, Lee AH, Keefe EB, Rome H, Coception W, Esquivel CO. Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol 1993; 88: 1337.
  • 31
    Tome S, Lucey MR. Timing of liver transplantation in alcoholic cirrhosis. J Hepatol 2003; 39: 302.
  • 32
    Pageaux GP, Perney P, Larrey D. Liver transplantation for alcoholic liver disease. Addict Biol 2001; 6: 301.
  • 33
    Tome’ S, Martinez-Rey C, Gonzalez-Quintela A, et al. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol 2002; 36: 793.
  • 34
    Burra P, Smedile A, Angelico M, Ascione A, Rizzetto M. Liver transplantation in Italy: current status. Dig Liver Dis 2000; 32: 249.
  • 35
    Bernard PH, Le Bail B, Carles J, Balabaud C, Biulac-Sage P. Liver retransplantation for alcoholic cirrhosis recurring within a 21-month period. Transplant Int 1996; 9(5): 524.
  • 36
    Pereira SP, Williams R. Alcohol relapse and functional outcome after liver transplantation for alcoholic liver disease. Liver Transpl 2001; 7: 204205.
  • 37
    Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003; 38: 629.
  • 38
    Fuller RK. Definition and diagnosis of relapse to drinking. Liver Transplant Surg 1997; 3: 258.
    Direct Link:
  • 39
    Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001; 7: 418.
  • 40
    Burra P, Mioni D, Cillo U, et al. Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease. Transplant Int 2000; 13: S174.
  • 41
    Tang H, Boulton R, Gunson B, Hubscher S, Neuberger J. Patterns of alcohol consumption after liver transplantation. Gut 1998; 43: 140.
  • 42
    Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of liver allograft. J Hepatol 2001; 34: 762.
  • 43
    Pageaux GP, Michel J, Costes V, et al. Alcoholic cirrhosis is a good indication for liver transplantation even for cases of recidivism. Gut 1999; 45: 421.
  • 44
    Pera M, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for alcoholic cirrhosis with anti-HCV antibodies. Transplant Int 1997; 10: 289.
  • 45
    Weinreib RM, Van Horn DV, McLellan T, et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics 2001; 42: 110.
  • 46
    Weinreib RM, Van Horn DV, McLellan T, Volpicelli JR, Calarco JS, Lucey MR. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates. J Addict Disease 2001; 20: 105.
  • 47
    Berlakovich GA, Rockenschaub S, Taucher S, et al. Underlying disease as a predictor for rejection after liver transplantation. Arch Surg 1998; 133: 167.
  • 48
    Farges O, Saliba F, Farhmant H, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23: 240.
  • 49
    Platz KP, Mueller AR, Spree E, et al. Liver transplantation for alcoholic cirrhosis. Transplant Int 2000; 13: S127.
  • 50
    Dam M, Burra P, Tedeschi U, et al. Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J Hepatol 1998; 29: 78.
  • 51
    Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation. Hepatology 2001; 34: 84.
  • 52
    Duvoux C, Delacroix I, Richardet JP, et al. Increased incidence of oropharyngeal squamous cell carcinoma after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67: 418.
  • 53
    De Bona M, Ponton P, Ermani M, et al. The impact of liver disease and medical complications on quality of life and psychosocial distress before and after liver transplantation. J Hepatol 2000; 33: 609.
  • 54
    Cowling T, Jennings LW, Jung GS, et al. Comparing quality of life following liver transplantation for Laennaec versus non-Laennaec's patients. Clin Transpl 2000; 14: 115.
  • 55
    Pereira SP, Howard LM, Muiesan P, Rela M, Heaton N, Williams R. Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl 2000; 6: 762.
  • 56
    Stewart SF, Day CP. The management of alcoholic liver disease. J Hepatol 2003; 38: S2.
  • 57
    Berlakovic GA, Langer F, Freundorfer E, et al. General compliance after liver transplantation for alcoholic cirrhosis. Transplant Int 2000; 13: 129.
  • 58
    Cowling T, Jennings LW, Goldstein RM, et al. Societal reintegration after liver transplantation. Findings in alcohol-related and non-alcohol related transplant recipients. Ann Surg 2004; 239: 93.